BIOMAT Database Logo BIOMAT Database Logo

Staphylococcus aureus osteomyelitis in Hawaii. 2010

Guliz Erdem, and Raymond Salazar, and Chieko Kimata, and Thitiwan Simasathien, and Kyra A Len, and Lora Bergert, and Marian Melish
Department of Pediatrics, University of Hawaii, Honolulu, HI 96826, USA. guliz@hawaii.edu

BACKGROUND The clinical and laboratory findings and outcomes of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) Staphylococcus aureus osteomyelitis have not been studied in Hawaii. METHODS Retrospective inpatient chart reviews of 62 culture-proven osteomyelitis patients between 1996 and 2007 were performed. RESULTS Fifteen patients (24%) had MRSA infection, and 47 patients (76%) had MSSA infection. Length of stay, chronic health problems, total duration of fever, and length of treatment were not significantly different between MRSA- and MSSA-infected patients. The peak erythrocyte sedimentation rate and C-reactive protein values were higher among MRSA infected patients (P values: .009 and .003, respectively).The systemic complication rate was higher in MRSA-infected patients (P value: .018). CONCLUSIONS Differing from other pediatric staphylococcal infections in Hawaii, the majority of the patients had MSSA infection. Pacific Islander and Native Hawaiian ethnicities were affected disproportionately and had MRSA infection more frequently. MRSA-infected patients had frequent surgical procedures and systemic complications.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010019 Osteomyelitis INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA. Osteomyelitides
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D005260 Female Females
D006254 Hawaii A group of islands in Polynesia, in the north central Pacific Ocean, comprising eight major and 114 minor islands, largely volcanic and coral. Its capital is Honolulu. It was first reached by Polynesians about 500 A.D. It was discovered and named the Sandwich Islands in 1778 by Captain Cook. The islands were united under the rule of King Kamehameha 1795-1819 and requested annexation to the United States in 1893 when a provisional government was set up. Hawaii was established as a territory in 1900 and admitted as a state in 1959. The name is from the Polynesian Owhyhii, place of the gods, with reference to the two volcanoes Mauna Kea and Mauna Loa, regarded as the abode of the gods. (From Webster's New Geographical Dictionary, 1988, p493 & Room, Brewer's Dictionary of Names, 1992, p2330) Midway Island,Midway Islands

Related Publications

Guliz Erdem, and Raymond Salazar, and Chieko Kimata, and Thitiwan Simasathien, and Kyra A Len, and Lora Bergert, and Marian Melish
[Staphylococcus aureus osteomyelitis in children].
January 2022, Nederlands tijdschrift voor geneeskunde,
Guliz Erdem, and Raymond Salazar, and Chieko Kimata, and Thitiwan Simasathien, and Kyra A Len, and Lora Bergert, and Marian Melish
Methicillin-resistant Staphylococcus aureus osteomyelitis.
September 1985, Clinical orthopaedics and related research,
Guliz Erdem, and Raymond Salazar, and Chieko Kimata, and Thitiwan Simasathien, and Kyra A Len, and Lora Bergert, and Marian Melish
Osteomyelitis and intraosteoblastic Staphylococcus aureus.
January 2007, Journal of surgical orthopaedic advances,
Guliz Erdem, and Raymond Salazar, and Chieko Kimata, and Thitiwan Simasathien, and Kyra A Len, and Lora Bergert, and Marian Melish
Haematogenous osteomyelitis and Staphylococcus aureus.
February 1981, Prostaglandins and medicine,
Guliz Erdem, and Raymond Salazar, and Chieko Kimata, and Thitiwan Simasathien, and Kyra A Len, and Lora Bergert, and Marian Melish
Methicillin-resistant Staphylococcus aureus, Hawaii, 2000-2002.
August 2005, Emerging infectious diseases,
Guliz Erdem, and Raymond Salazar, and Chieko Kimata, and Thitiwan Simasathien, and Kyra A Len, and Lora Bergert, and Marian Melish
Experimental hematogenous osteomyelitis by Staphylococcus aureus.
January 1997, Clinical orthopaedics and related research,
Guliz Erdem, and Raymond Salazar, and Chieko Kimata, and Thitiwan Simasathien, and Kyra A Len, and Lora Bergert, and Marian Melish
Serological diagnosis of Staphylococcus aureus osteomyelitis.
May 1985, Journal of clinical microbiology,
Guliz Erdem, and Raymond Salazar, and Chieko Kimata, and Thitiwan Simasathien, and Kyra A Len, and Lora Bergert, and Marian Melish
Osteomyelitis with methicillin-resistant Staphylococcus aureus.
July 1986, The Journal of hospital infection,
Guliz Erdem, and Raymond Salazar, and Chieko Kimata, and Thitiwan Simasathien, and Kyra A Len, and Lora Bergert, and Marian Melish
Tolerant Staphylococcus aureus causing vertebral osteomyelitis.
March 1982, Archives of internal medicine,
Guliz Erdem, and Raymond Salazar, and Chieko Kimata, and Thitiwan Simasathien, and Kyra A Len, and Lora Bergert, and Marian Melish
The osteoblast secretome in Staphylococcus aureus osteomyelitis.
January 2022, Frontiers in immunology,
Copied contents to your clipboard!